BBIO
BridgeBio Pharma, Inc.Company with tickers: BBIO
CIK
1743881
CUSIP
10806X102
Shares Outstanding
195,861,242
Website
https://investor.bridgebio.com
13F Activity (30d)
17 filings
12 filers
Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.
Holders: 1
Total Value: $707,439,038
Total Shares: 10,226,063
Institutional Ownership Trend
33 quarters
Superinvestors Holding BBIO
All superinvestors →Quarterly Activity
vs Mar 31, 2026
New
1
Increased
0
Decreased
0
Sold Out
462
Unchanged
0
Holder count:
-461
Institutional value:
-95.4%
Shares held:
-95.1%
Top New Positions
vs Mar 31, 2026| Institution | Acquired | Value (USD) | Open |
|---|---|---|---|
| — Dapice Joshua J. | 10,226,063 | $707,439,038 |
Top Sold-Out Positions
vs Mar 31, 2026| Institution | Previously Held | Last Value (USD) | Open |
|---|---|---|---|
| Mega BlackRock, Inc. | 14,207,757 | $1,055,068,026 | |
| Mid Kohlberg Kravis Roberts & Co. L.P. | 13,260,971 | $984,759,706 | |
| Mega JANUS HENDERSON GROUP PLC | 13,179,013 | $978,673,503 | |
| Large VIKING GLOBAL INVESTORS LP | 11,842,434 | $879,419,148 | |
| Large FARALLON CAPITAL MANAGEMENT LLC | 9,365,463 | $695,479,282 |
| Holder | Value (USD) | % of 13F | Shares | Type | Discretion | Filed | Open | |||
|---|---|---|---|---|---|---|---|---|---|---|
| — Dapice Joshua J. | $707,439,038 | 100.00% | 10,226,063 | Shares | Sole | 2026-05-29 | ||||
| No holders match your search. | ||||||||||